Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
- Peters, Anne L.
- Buschur, Elizabeth O.
- Buse, John B.
- Cohan, Pejman
- Diner, Jamie C.
- Hirsch, Irl B.
Publication date
January 2015
DOIAbstract
Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis (euDKA) in hopes that it will enhance recognition of this potentially life-threatening complication
Add to ORKG